Cargando…

Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study

BACKGROUND: Telemedicine use in chronic disease management has markedly increased during health emergencies due to COVID-19. Diabetes and technologies supporting diabetes care, including glucose monitoring devices, software analyzing glucose data, and insulin delivering systems, would facilitate rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parise, Martina, Tartaglione, Linda, Cutruzzolà, Antonio, Maiorino, Maria Ida, Esposito, Katherine, Pitocco, Dario, Gnasso, Agostino, Irace, Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025914/ https://www.ncbi.nlm.nih.gov/pubmed/33769945 http://dx.doi.org/10.2196/24552

Ejemplares similares

Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study
por: Irace, Concetta, et al.
Publicado: (2019)

Effect of Extra Virgin Olive Oil and Butter on Endothelial Function in Type 1 Diabetes
por: Cutruzzolà, Antonio, et al.
Publicado: (2021)

Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study
por: Parise, Martina, et al.
Publicado: (2022)

A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study
por: Parise, Martina, et al.
Publicado: (2023)

Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
por: Tripolino, Cesare, et al.
Publicado: (2019)

The Effect of Two Different Insulin Formulations on Postprandial Hyperglycemia after High and Low Glycemic-Index Meal in Type 1 Diabetes
por: Cutruzzolà, Antonio, et al.
Publicado: (2022)

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2020)

An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes
por: Maiorino, Maria Ida, et al.
Publicado: (2023)

Hypoglycemia does not affect the progression of preclinical atherosclerosis in subjects with type 2 diabetes
por: Irace, Concetta, et al.
Publicado: (2019)

Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy
por: Cutruzzolà, Antonio, et al.
Publicado: (2023)

Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
por: Irace, Concetta, et al.
Publicado: (2018)

Functional and morphological cardiovascular alterations associated with neurofibromatosis 1
por: Cutruzzolà, Antonio, et al.
Publicado: (2020)

Diabetes Data Management System to Improve Glycemic Control in People With Type 1 Diabetes: Prospective Cohort Study
por: Irace, Concetta, et al.
Publicado: (2017)

Evidence for congruent impairment in micro and macrovascular function in type 1 diabetes
por: Irace, Concetta, et al.
Publicado: (2017)

Effectiveness of teleassistance on the improvement of health related quality of life in people with neuromuscular diseases
por: Martínez, Oscar, et al.
Publicado: (2012)

Teleassistance and teleconsultation using smartphones and its contribution in clinical progress of oral and maxillofacial surgery
por: Singh, Gaurav, et al.
Publicado: (2020)

Effects of Teleassistance on the Quality of Life of People With Rare Neuromuscular Diseases According to Their Degree of Disability
por: Martínez, Oscar, et al.
Publicado: (2021)

Management of Type 2 Diabetes Mellitus through Telemedicine
por: Carallo, Claudio, et al.
Publicado: (2015)

Type 1 diabetes recurrence after SARS‐CoV‐2 infection in a subject with pancreas transplantation
por: Popolla, Valentina, et al.
Publicado: (2022)

COVID-19 teleassistance and teleconsultation: a matched case-control study (MIRATO project, Lombardy, Italy)
por: Bernocchi, Palmira, et al.
Publicado: (2023)

Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?
por: Caruso, Paola, et al.
Publicado: (2020)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Effect of a model based on education and teleassistance for the management of obstetric emergencies in 10 rural populations from Colombia
por: Escobar, María Fernanda, et al.
Publicado: (2022)

A Novel GCK Large Genomic Rearrangement in a Patient with MODY-2 Detected by Clinical Exome Sequencing
por: Concolino, Paola, et al.
Publicado: (2022)

Serum Calcium Increase Correlates With Worsening of Lipid Profile: An Observational Study on a Large Cohort From South Italy
por: Gallo, Luigia, et al.
Publicado: (2016)

Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
por: Maiorino, Maria Ida, et al.
Publicado: (2013)

Up and down waves of glycemic control and lower-extremity amputation in diabetes
por: Caruso, Paola, et al.
Publicado: (2021)

Diabetic neuropathy: a risk factor for severe COVID-19?
por: Pitocco, Dario, et al.
Publicado: (2021)

Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Giugliano, Dario, et al.
Publicado: (2011)

Diabetes and sexual dysfunction: current perspectives
por: Maiorino, Maria Ida, et al.
Publicado: (2014)

PTH-rP and PTH-R1 Expression in Placentas from Pregnancies Complicated by Gestational Diabetes: New Insights into the Pathophysiology of Hyperglycemia in Pregnancy
por: Sirico, Angelo, et al.
Publicado: (2021)

Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
por: Giugliano, Dario, et al.
Publicado: (2019)

Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?
por: Pitocco, Dario, et al.
Publicado: (2020)

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
por: Pitocco, Dario, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin
por: Capuano, Annalisa, et al.
Publicado: (2013)

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
por: Longo, Miriam, et al.
Publicado: (2020)

A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses
por: Esposito, Katherine, et al.
Publicado: (2015)

SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
por: Longo, Miriam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3jifu48oj66oim1j2vl01890bs